Alteration of histone acetylation pattern during long-term serum-free culture conditions of human fetal placental mesenchymal stem cells

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Zhu, Yongzhao ^a,b   Song, Xumei ^b   Han, Fei ^b   Li, Yukui ^b   Wei, Jun ^b   Liu, Xiaoming ^a,b  

^a NINGXIA UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE H3; HISTONE H4; OCTAMER TRANSCRIPTION FACTOR 4; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR SOX2; SERUM-FREE MEDIUM;

ARTICLE; CONTROLLED STUDY; CULTURE TECHNIQUE; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FETOPLACENTAL UNIT; FETUS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO PROPAGATION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STEM CELL CULTURE; TELOMERE HOMEOSTASIS; ACETYLATION; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; CYTOLOGY; GENETICS; KINETICS; MESENCHYMAL STROMA CELL; METABOLISM; MUTATION; ONCOGENE; PLACENTA; PREGNANCY; SERUM-FREE MEDIUM; TELOMERE; TIME FACTOR;

ACETYLATION; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; DOWN-REGULATION; FEMALE; FETUS; HISTONE DEACETYLASES; HISTONES; HUMANS; KINETICS; MALE; MESENCHYMAL STROMAL CELLS; MUTATION; ONCOGENES; PLACENTA; PREGNANCY; TELOMERE; TIME FACTORS;

EID: 84922840218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117068     Document Type: Article

References (62)

1. Leyva-Leyva M, Barrera L, Lopez-Camarillo C, Arriaga-Pizano L, Orozco-Hoyuela G, et al. (2013) Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential. Stem Cells Dev 22: 1275-1287. doi: 10.1089/scd.2012.0359 PMID: 23211052
2. Rebelatto CK, Aguiar AM, Moretao MP, Senegaglia AC, Hansen P, et al. (2008) Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233: 901-913. doi: 10.3181/0712-RM-356 PMID: 18445775
3. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, et al. (2004) Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22: 649-658. PMID: 15342929
4. Wegmeyer H, Broske AM, Leddin M, Kuentzer K, Nisslbeck AK, et al. (2013) Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev 22: 2606-2618. doi: 10.1089/scd.2013.0016 PMID: 23676112
5. Christodoulou I, Kolisis FN, Papaevangeliou D, Zoumpourlis V (2013) Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for Cytotherapy. Stem Cells Int 2013: 246134. doi: 10.1155/2013/246134 PMID: 23533440
6. Meraviglia V, Vecellio M, Grasselli A, Baccarin M, Farsetti A, et al. (2012) Human chorionic villus mesenchymal stromal cells reveal strong endothelial conversion properties. Differentiation 83: 260-270. doi: 10.1016/j.diff.2012.02.006 PMID: 22466671
7. Lv F, Lu M, Cheung KM, Leung VY, Zhou G (2012) Intrinsic properties of mesemchymal stem cells from human bone marrow, umbilical cord and umbilical cord blood comparing the different sources of MSC. Curr Stem Cell Res Ther 7: 389-399. PMID: 22934544
8. Poloni A, Maurizi G, Babini L, Serrani F, Berardinelli E, et al. (2011) Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion. Cell Transplant 20: 643-654. doi: 10.3727/096368910X536518 PMID: 21054927
9. Jo CH, Kim OS, Park EY, Kim BJ, Lee JH, et al. (2008) Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res 334: 423-433. doi: 10.1007/s00441-008-0696-3 PMID: 18941782
10. Zhu Y, Song X, Wang J, Li Y, Yang Y, et al. (2014) Placental mesenchymal stem cells of fetal origin deposit epigenetic alterations during long-term culture under serum-free condition. Expert Opin Biol Ther: 1-18. PMID: 25539575
11. Zhu Y, Yang Y, Zhang Y, Hao G, Liu T, et al. (2014) Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther 5: 48. doi: 10.1186/scrt436 PMID: 24721710
12. Binato R, de Souza Fernandez T, Lazzarotto-Silva C, Du Rocher B, Mencalha A, et al. (2013) Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif 46:10-22. doi: 10.1111/cpr.12002 PMID: 23163975
13. Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, et al. (2009) Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 219: 294-305. doi: 10.1002/path.2603 PMID: 19718709
14. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, et al. (2007) Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25: 371-379. PMID: 17038675
15. Bork S, Pfister S, Witt H, Horn P, Korn B, et al. (2010) DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54-63. doi: 10.1111/j.1474-9726.2009.00535.x PMID: 19895632
16. Li Y, Chu JS, Kurpinski K, Li X, Bautista DM, et al. (2011) Biophysical regulation of histone acetylation in mesenchymal stem cells. Biophys J 100: 1902-1909. doi: 10.1016/j.bpj.2011.03.008 PMID: 21504726
17. Redaelli S, Bentivegna A, Foudah D, Miloso M, Redondo J, et al. (2012) From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 3: 47. doi: 10.1186/scrt138 PMID: 23168092
18. Teng IW, Hou PC, Lee KD, Chu PY, Yeh KT, et al. (2011) Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res 71: 4653-4663. doi: 10.1158/0008-5472.CAN-10-3418 PMID: 21518779
19. Li H, Fan X, Kovi RC, Jo Y, Moquin B, et al. (2007) Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 67: 10889-10898. PMID: 18006834
20. Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, et al. (2006) Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24: 1095-1103. PMID: 16282438
21. Chen G, Yue A, Ruan Z, Yin Y, Wang R, et al. (2014) Human umbilical cord-derived mesenchymal stem cells do not undergo malignant transformation during long-term culturing in serum-free medium. PLoS One 9: e98565. doi: 10.1371/journal.pone.0098565 PMID: 24887492
22. Gou S, Wang C, Liu T, Wu H, Xiong J, et al. (2010) Spontaneous differentiation of murine bone marrow-derived mesenchymal stem cells into adipocytes without malignant transformation after long-term culture. Cells Tissues Organs 191: 185-192. doi: 10.1159/000240246 PMID: 19776549
23. Tang Q, Chen Q, Lai X, Liu S, Chen Y, et al. (2013) Malignant transformation potentials of human umbilical cord mesenchymal stem cells both spontaneously and via 3-methycholanthrene induction. PLoS One 8: e81844. doi: 10.1371/journal.pone.0081844 PMID: 24339974
24. Li Z, Liu C, Xie Z, Song P, Zhao RC, et al. (2011) Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One 6: e20526. doi: 10.1371/journal.pone.0020526 PMID: 21694780
25. Wang L, Yang Y, Zhu Y, Ma X, Liu T, et al. (2012) Characterization of placenta-derived mesenchymal stem cells cultured in autologous human cord blood serum. Mol Med Rep 6: 760-766. doi: 10.3892/mmr.2012.1000 PMID: 22824952
26. Pfaffl MW(2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. PMID: 11328886
27. Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37: e21. doi: 10.1093/nar/gkn1027 PMID: 19129229
28. Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506. PMID: 17664353
29. Patel DM, Shah J, Srivastava AS (2013) Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int 2013: 496218. doi: 10.1155/2013/496218 PMID: 23577036
30. Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28: 585-596. doi: 10.1002/stem.269 PMID: 19967788
31. Musina RA, Bekchanova ES, Belyavskii AV, Sukhikh GT (2006) Differentiation potential of mesenchymal stem cells of different origin. Bull Exp Biol Med 141: 147-151. PMID: 16929987
32. Musina RA, Bekchanova ES, Sukhikh GT (2005) Comparison of mesenchymal stem cells obtained from different human tissues. Bull Exp Biol Med 139: 504-509. PMID: 16027890
33. Kong P, Xie X, Li F, Liu Y, Lu Y (2013) Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem Biophys Res Commun 438: 410-419. doi: 10.1016/j.bbrc.2013.07.088 PMID: 23899518
34. Pievani A, Scagliotti V, Russo FM, Azario I, Rambaldi B, et al. (2014) Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential. Cytotherapy 16: 893-905. doi: 10.1016/j.jcyt.2014.02.008 PMID: 24794181
35. Guo L, Zhou Y, Wang S, Wu Y (2014) Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids. J Cell Mol Med. doi: 10.1111/jcmm.12509 PMID: 25545142
36. Ho JH, Chen YF, Ma WH, Tseng TC, Chen MH, et al. (2011) Cell contact accelerates replicative senescence of human mesenchymal stem cells independent of telomere shortening and p53 activation: roles of Ras and oxidative stress. Cell Transplant 20: 1209-1220. doi: 10.3727/096368910X546562 PMID: 21176396
37. Mark P, Kleinsorge M, Gaebel R, Lux CA, Toelk A, et al. (2013) Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium. Stem Cells Int 2013: 698076. doi: 10.1155/2013/698076 PMID: 24194767
38. Wagner W (2012) Implications of long-term culture for mesenchymal stem cells: genetic defects or epigenetic regulation? Stem Cell Res Ther 3: 54. doi: 10.1186/scrt145 PMID: 23257053
39. Witt O, Deubzer HE, Milde T, Oehme I (2009) HDAC family: What are the cancer relevant targets? Cancer Lett 277: 8-21. doi: 10.1016/j.canlet.2008.08.016 PMID: 18824292
40. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737-749. PMID: 12429021
41. Cosentino C, Mostoslavsky R (2013) Metabolism, longevity and epigenetics. Cell Mol Life Sci 70: 1525-1541. doi: 10.1007/s00018-013-1295-3 PMID: 23467663
42. Hagelkruys A, Sawicka A, Rennmayr M, Seiser C (2011) The biology of HDAC in cancer: the nuclear and epigenetic components. Handb Exp Pharmacol 206: 13-37. doi: 10.1007/978-3-642-21631-2-2 PMID: 21879444
43. Atadja PW (2011) HDAC inhibitors and cancer therapy. Prog Drug Res 67: 175-195. PMID: 21141730
44. Li X, Zhang J, Xie Y, Jiang Y, Yingjie Z, et al. (2014) Progress of HDAC inhibitor panobinostat in the treatment of cancer. Curr Drug Targets 15: 622-634. PMID: 24597570
45. Lee S, Park JR, Seo MS, Roh KH, Park SB, et al. (2009) Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif 42: 711-720. doi: 10.1111/j.1365-2184.2009.00633.x PMID: 19689470
46. Wang J, Pursell NW, Samson ME, Atoyan R, Ma AW, et al. (2013) Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion. Mol Cancer Ther 12: 925-936. doi: 10.1158/1535-7163.MCT-12-1045 PMID: 23536719
47. Xu S, De Veirman K, Evans H, Santini GC, Vande Broek I, et al. (2013) Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacol Sin 34: 699-709. doi: 10.1038/aps.2012.182 PMID: 23564084
48. Kang ZH, Wang CY, Zhang WL, Zhang JT, Yuan CH, et al. (2014) Histone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression. PLoS One 9: e98894. doi: 10.1371/journal.pone.0098894 PMID: 24896240
49. Aldana-Masangkay GI, Sakamoto KM (2011) The role of HDAC6 in cancer. J Biomed Biotechnol 2011: 875824. doi: 10.1155/2011/875824 PMID: 21076528
50. Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, et al. (2010) HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res 16: 3240-3252. doi: 10.1158/1078-0432.CCR-10-0395 PMID: 20413433
51. Zhou XG, Yang Y, Yang JS, Zhou J, Fang TL, et al. (2011) Granulocyte-macrophage colony-stimulating factor and interleukin 4 induce the malignant transformation of the bone marrow-derived human adult mesenchymal stem cells. Chin Med J (Engl) 124: 729-733. PMID: 21518567
52. Zhang S, Han Z, Kong Q, Wang J, Sun B, et al. (2010) Malignant transformation of rat bone marrow-derived mesenchymal stem cells treated with 4-nitroquinoline 1-oxide. Chem Biol Interact 188: 119-126. doi: 10.1016/j.cbi.2010.06.008 PMID: 20599846
53. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015. PMID: 7605428
54. Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791. PMID: 9282118
55. Ouellette MM, Wright WE, Shay JW (2011) Targeting telomerase-expressing cancer cells. J Cell Mol Med 15: 1433-1442. doi: 10.1111/j.1582-4934.2011.01279.x PMID: 21332640
56. Sampedro Camarena F, Cano Serral G, Sampedro Santalo F (2007) Telomerase and telomere dynamics in ageing and cancer: current status and future directions. Clin Transl Oncol 9: 145-154. PMID: 17403625
57. Shay JW, Wright WE (2011) Role of telomeres and telomerase in cancer. Semin Cancer Biol 21: 349-353. doi: 10.1016/j.semcancer.2011.10.001 PMID: 22015685
58. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, et al. (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3: e2213. doi: 10.1371/journal.pone.0002213 PMID: 18493317
59. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, et al. (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7: 14. PMID: 16529651
60. Yamaoka E, Hiyama E, Sotomaru Y, Onitake Y, Fukuba I, et al. (2011) Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells. Int J Oncol 39: 5-11. doi: 10.3892/ijo.2011.1029 PMID: 21573488
61. He L, Zheng Y, Wan Y, Song J (2014) A shorter telomere is the key factor in preventing cultured human mesenchymal stem cells from senescence escape. Histochem Cell Biol. PMID: 25534592
62. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, et al. (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67: 9142-9149. PMID: 17909019